Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

eVox System

K-Number: K171781 · 2017-12-13

Decision Date2017-12-13
Product CodeGWQ
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

eVox System is the device name listed in this FDA 510(k) record. The listed applicant is Evoke Neuroscience, Inc.. It received FDA 510(k) clearance on 2017-12-13 under 510(k) number K171781. The device is classified under product code GWQ. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the eVox System?

eVox System is a medical device that received FDA 510(k) clearance on 2017-12-13. The listed applicant is Evoke Neuroscience, Inc.. The 510(k) number is K171781.

When did eVox System receive FDA 510(k) clearance?

eVox System received FDA 510(k) clearance on 2017-12-13, under 510(k) number K171781.

Who is the listed applicant for eVox System?

The FDA 510(k) record lists Evoke Neuroscience, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for eVox System?

The FDA product code for eVox System is GWQ.

Related Devices (Code: GWQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.